These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23951600)

  • 21. Development of hepatocellular carcinoma after sustained response to interferon therapy: how long should sustained responders with risk factors be followed?
    Kasahara A
    J Gastroenterol; 2005 Feb; 40(2):220-2. PubMed ID: 15770412
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
    Fukuda A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
    [No Abstract]   [Full Text] [Related]  

  • 23. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H; Lok AS
    Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of hepatocellular carcinoma.
    Craxì A; Cammà C
    Clin Liver Dis; 2005 May; 9(2):329-46, viii. PubMed ID: 15831277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic hepatitis C and prevention of hepatocellular carcinoma.
    Chayama K
    J Gastroenterol; 2002; 37 Suppl 13():69-73. PubMed ID: 12109670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term cohort study of chronic hepatitis C according to interferon efficacy.
    Maruoka D; Imazeki F; Arai M; Kanda T; Fujiwara K; Yokosuka O
    J Gastroenterol Hepatol; 2012 Feb; 27(2):291-9. PubMed ID: 21793911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis C and liver transplantation].
    Durand F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interferon therapy to chronic hepatitis type C for the prevention of hepatocarcinogenesis].
    Ichida T; Ohkoshi S; Takimoto M; Ishikawa T
    Nihon Rinsho; 2001 Jul; 59(7):1331-7. PubMed ID: 11494547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cirrhosis due to hepatitis C virus].
    Trinchet JC
    Rev Prat; 2000 May; 50(10):1094-9. PubMed ID: 10905095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].
    Ebinuma H; Saito H
    Nihon Rinsho; 2011 May; 69 Suppl 4():540-5. PubMed ID: 22096977
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of hepatocellular carcinogenesis by interferon].
    Ikeda K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.
    Omata M; Yoshida H; Shiratori Y
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S141-3. PubMed ID: 16234063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
    Lin A; Kadam JS; Bodenheimer HC; Leonard J; Joyce MA; Lake-Bakaar G
    J Med Virol; 2008 Aug; 80(8):1350-3. PubMed ID: 18551608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic hepatitis C?
    Kowdley KV
    Gastroenterology; 1999 Sep; 117(3):738-9. PubMed ID: 10464154
    [No Abstract]   [Full Text] [Related]  

  • 37. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
    Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 39. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
    Vezali E; Aghemo A; Lampertico P; Colombo M
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):455-64. PubMed ID: 21435968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.
    Shiratori Y; Ito Y; Yokosuka O; Imazeki F; Nakata R; Tanaka N; Arakawa Y; Hashimoto E; Hirota K; Yoshida H; Ohashi Y; Omata M;
    Ann Intern Med; 2005 Jan; 142(2):105-14. PubMed ID: 15657158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.